{"nctId":"NCT01385202","briefTitle":"THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation","startDateStruct":{"date":"2011-06"},"conditions":["Heart Diseases","Arrhythmia","Atrial Fibrillation"],"count":172,"armGroups":[{"label":"THERMOCOOL® SMARTTOUCH™ Catheter","type":"EXPERIMENTAL","interventionNames":["Device: THERMOCOOL® SMARTTOUCH™ Catheter"]}],"interventions":[{"name":"THERMOCOOL® SMARTTOUCH™ Catheter","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Have had at least 3 atrial fibrillation episodes within 6 months of this study\n* Have failed at least one antiarrhythmic drug shown by repeated atrial fibrillation episodes\n* 18 years of age or older\n\nExclusion Criteria:\n\n* Have had previous ablation for atrial fibrillation\n* Have take amiodarone within 6 months of this study\n* Have had any heart surgery within the last 60 days\n* Have had a heart attack within the last 60 days\n* Females who are pregnant or breast feeding","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"The Rate of Subjects Who Were Free From Documented Symptomatic Atrial Fibrillation (AF), Atrial Tachycardia (AT), or Atrial Flutter (AFL) Episodes Through 12-month Follow-up","description":"The primary effectiveness endpoint for this study will be freedom from documented symptomatic atrial fibrillation (AF), atrial tachycardia (AT), or atrial flutter (AFL) episodes through 12-month follow-up (includes a three month blanking period).","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"70.2","spread":null}]}]}]},{"type":"PRIMARY","title":"Incidence of Early Onset (Within 7 Days of the AF Ablation Procedure) Primary Adverse Events.","description":"Primary adverse events (AE) include Death, Myocardial infarction (MI), Pulmonary vein (PV) stenosis, Diaphragmatic paralysis, Atrio-esophageal fistula, Transient Ischemic Attack (TIA), Stroke / Cerebrovascular accident (CVA), Thromboembolism, Pericarditis, Cardiac Tamponade, Pericardial effusion, Pneumothorax, Atrial perforation, Vascular Access Complications, Pulmonary edema, Hospitalization (initial and prolonged), and Heart block.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Rate of Acute Success","description":"Acute success is defined as confirmation of entrance block in all Pulmonary veins (PV).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"94.7","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":38,"n":161},"commonTop":["SHORTNESS OF BREATH","ATRIAL FIBRILLATION RECURRENCE","ATRIAL FLUTTER","HOSPITALIZATION, INTIAL AND PROLONGED","HYPOTENSION"]}}}